Most Recent

image: Evolving Pain Resistance

Evolving Pain Resistance

By | October 24, 2013

Grasshopper mice harbor mutations in a pain-transmitting sodium channel that allow them to prey on highly toxic bark scorpions.

2 Comments

image: Measuring Latent HIV

Measuring Latent HIV

By | October 24, 2013

The latent HIV provirus reservoir persisting in CD4+ T cells is potentially 60 times larger than previously believed, researchers show.

0 Comments

image: Implanted Trachea Going Strong

Implanted Trachea Going Strong

By | October 23, 2013

Five years after receiving a tissue-engineered airway, the 30-year-old Colombian patient is doing well, having experienced no immunological complications associated with the procedure.

0 Comments

image: A Dire Air Pollution Warning

A Dire Air Pollution Warning

By | October 21, 2013

Contaminants in the air are officially carcinogens, according to the World Health Organization.

2 Comments

image: FDA Considers Three-Parent IVF

FDA Considers Three-Parent IVF

By | October 17, 2013

The US regulatory agency will meet next week to discuss whether to allow human trials of a technique that combines the genetic information of three adults.

0 Comments

image: Ketamine Alternative Shows Promise

Ketamine Alternative Shows Promise

By | October 17, 2013

Researchers show that lanicemine is an effective antidepressant without the adverse effects of the related hallucinogenic drug.

0 Comments

image: Italian Stem Cell Trial Stopped

Italian Stem Cell Trial Stopped

By | October 11, 2013

With support from scientists, Italy’s health minister halts a controversial clinical trial.

1 Comment

image: Fighting Viruses with RNAi

Fighting Viruses with RNAi

By | October 10, 2013

The long-debated issue of whether mammals can use RNA interference as an antiviral defense mechanism is finally put to rest.

0 Comments

image: Mislabeled Microbes Cause Two Retractions

Mislabeled Microbes Cause Two Retractions

By | October 10, 2013

Two papers on plant immunity have been retracted, and questions remain about others with similar results. 

9 Comments

image: Geron’s Stem Cell Program Sold

Geron’s Stem Cell Program Sold

By | October 2, 2013

The company, which launched the first ever clinical trial for a human embryonic stem cell therapy before shuttering its stem cell arm, has finally struck a deal with BioTime.

0 Comments

Popular Now

  1. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. What Sensory Receptors Do Outside of Sense Organs
RayBiotech